Small Macular Holes Treated With Air

Last updated: November 4, 2024
Sponsor: Helse Stavanger HF
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Postoperative intraocular tamponade

Clinical Study ID

NCT06211907
REK 580226
  • Ages > 18
  • All Genders

Study Summary

Non-inferiority trial comparing intraocular air and gas tamponade for closure of macular holes.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Primary MH ≤250 μm

  • MH duration ≤12 months

  • No previous vitreoretinal surgery in study eye

  • Ability to sign informed consent

  • Signed informed consent

  • Age ˃18 years

Exclusion

Exclusion Criteria:

  • Previous vitreoretinal surgery in study eye

  • Secondary MH caused by other conditions than vitreomacular traction

  • Myopic MH, i.e., excessive myopia (more than -6 dioptres)

  • Traumatic MH

  • MH secondary to retinal detachment or other retinal diseases

  • Previously participation in this study

Study Design

Total Participants: 132
Treatment Group(s): 1
Primary Treatment: Postoperative intraocular tamponade
Phase:
Study Start date:
July 14, 2024
Estimated Completion Date:
June 30, 2028

Connect with a study center

  • Department of Ophthalmology, University of Thessaly

    Thessaly, 38221
    Greece

    Site Not Available

  • Stavanger University Hospital

    Stavanger, Rogaland 4026
    Norway

    Active - Recruiting

  • University Hospital of Northern Norway

    Tromsø, Troms 9019
    Norway

    Active - Recruiting

  • St. Olavs University Hospital

    Trondheim, Tronderlag 7030
    Norway

    Active - Recruiting

  • Haukeland University Hospital

    Bergen, Vestland 5021
    Norway

    Active - Recruiting

  • Oslo University Hospital

    Oslo, 0424
    Norway

    Active - Recruiting

  • Clinical Universitary Hospital of Santiago

    Santiago De Compostela, La Coruna 15706
    Spain

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.